Inventor · disambiguated record
Catherine Stace
Also filed as: STACE CATHERINE · STACE CATHERINE LUCY
18 granted patents·9 pending applications·273 citations·filing 2012–2025
95Inventor score
Top patents by PatentIndex Score
27 records- 0196US11672868B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2021·Granted Jun 13, 2023·16 cites·19 claims
- 0296US11103591B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2019·Granted Aug 31, 2021·20 cites·24 claims
- 0396US10792368B1Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2020·Granted Oct 6, 2020·23 cites·14 claims
- 0496US9932367B2Modification of polypeptidesBICYCLERD LTD·Filed 2015·Granted Apr 3, 2018·25 cites·13 claims
- 0595US10894808B2Polypeptide ligands specific for plasma kallikreinBICYCLERD LTD·Filed 2019·Granted Jan 19, 2021·17 cites·42 claims
- 0694US11623012B2Bicyclic peptide ligands specific for EphA2BICYCLERD LTD·Filed 2018·Granted Apr 11, 2023·15 cites·9 claims
- 0794US10800813B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2012·Granted Oct 13, 2020·24 cites·48 claims
- 0894US10532106B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2015·Granted Jan 14, 2020·32 cites·12 claims
- 0993US12318454B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2023·Granted Jun 3, 2025·1 cites·13 claims
- 1093US10294274B2Polypeptide ligands specific for plasma kallikreinBICYCLERD LTD·Filed 2014·Granted May 21, 2019·27 cites·2 claims
- 1193US10118947B2Modulation of structured polypeptide specificityBICYCLE THERAPEUTICS LTD·Filed 2014·Granted Nov 6, 2018·27 cites·6 claims
- 1293US9994617B2Modulation of structured polypeptide specificityBICYCLE THERAPEUTICS LTD·Filed 2012·Granted Jun 12, 2018·29 cites·5 claims
- 1392US10870679B2Modulation of structured polypeptide specificityBICYLERD LTD·Filed 2018·Granted Dec 22, 2020·17 cites·21 claims
- 1482US2025255975A1Bicyclic peptide ligands specific for mt1-mmpBICYCLERD LTD·Filed 2025·Application pending·0 cites
- 1568US11912794B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2020·Granted Feb 27, 2024·0 cites·19 claims
- 1668US11753444B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2020·Granted Sep 12, 2023·0 cites·21 claims
- 1759US12377155B2Bicyclic peptide ligands specific for PSMABICYCLERD LTD·Filed 2019·Granted Aug 5, 2025·0 cites·14 claims
- 1856US2014274759A1Modification of polypeptidesWALKER EDWARD·Filed 2013·Application pending·0 cites
- 1954US12350343B2Bicyclic peptide ligands specific for MT1-MMPBICYCLETX LTD·Filed 2019·Granted Jul 8, 2025·0 cites·17 claims
- 2052US12491253B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2019·Granted Dec 9, 2025·0 cites·15 claims
- 2151US2022008545A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR FAPaBICYCLERD LTD·Filed 2019·Application pending·0 cites
- 2250US2022024982A1Bicyclic peptide ligands specific for mt1-mmpBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 2349US2022064221A1Bicyclic peptide ligands specific for integrin alpha-v-beta-3BICYCLETX LTD·Filed 2020·Application pending·0 cites
- 2449US2022133733A1Bicyclic peptide ligands specific for cd38BICYCLERD LTD·Filed 2020·Application pending·0 cites
- 2549US2022133732A1Bicyclic peptide ligands specific for caixBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 2649US2022088118A1Bicyclic peptide ligands specific for caixBICYCLETX LTD·Filed 2020·Application pending·0 cites
- 2749US2022119488A1Bicyclic peptide ligands specific for integrin alpha-v-beta-3BICYCLERD LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Catherine Stace files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →